
A new collaborative network that facilitates remote training and access to advanced microscopy will strengthen research capability and capacity in the region.

University of Birmingham experts are leading a new initiative to help save the lives of thousands of women giving birth by c-section in developing nations.

A non-invasive imaging technique has shown potential in helping surgeons plan epilepsy operations.

Dr Caroline Gorvin has been awarded the distinguished Sir Henry Dale Fellowship worth nearly £1 million to better understand how food intake is regulated.

Scientists are calling for changes to healthcare policy following research showing the scale of the impact of a condition associated with benign tumours that can lead to type 2 diabetes and high blood pressure.
The anniversary autumn 2021 issue of The Endocrinologist includes an interview with Professor Wiebke Arlt, Director of the Institute of Metabolism and Systems Research (IMSR), University of Birmingham, about her career.

CARE Fertility has generously donated £202,800 to support the miscarriage research led by Professor Arri Coomarasamy and team at the University of Birmingham.
In this interview, News-Medical speaks to Professor Weibke Arlt about her recent research into how the contraceptive pill affects type 2 diabetes in women with PCOS.
Professor Chris McCabe, Professor of Molecular Endocrinology at the Institute of Metabolism and Systems Research, talks about the future of endocrinology research in the anniversary issue of The Endocrinologist.
New research reveals that Dr Abd Tahrani is featured as being in the top five most active social media users who participate in the UK's online diabetes debate and who has published the most diabetes related posts.
Professor Chris McCabe is featured in a British Thyroid Foundation news story about being awarded the Joe Plater BTF Thyroid Cancer Research Award 2021 for his thyroid cancer research.

A study led by the University of Birmingham has revealed for the first time that the contraceptive pill can reduce the risk of type 2 diabetes by over a quarter in women with polycystic ovary syndrome (PCOS).